Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
8.21
+0.11 (1.30%)
Feb 5, 2026, 4:00 PM EST - Market closed
Bioventus Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 27, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 10.17 | -33.54 | -156.23 | -158.7 | 19.38 | 16.41 |
Depreciation & Amortization | 17.3 | 19.14 | 26.82 | 29.97 | 20.47 | 28.64 |
Other Amortization | 5.58 | 5.58 | 6.69 | 4.45 | 2.23 | - |
Loss (Gain) From Sale of Assets | 0.37 | 0.29 | 3.58 | - | - | - |
Asset Writedown & Restructuring Costs | 2.46 | 36.36 | 78.62 | 124.7 | - | - |
Loss (Gain) From Sale of Investments | - | - | - | 3.89 | 1.54 | 1.09 |
Stock-Based Compensation | 8.03 | 10.06 | 2.72 | 17.59 | 19.84 | - |
Provision & Write-off of Bad Debts | 1.12 | -0.43 | -1.1 | 5.19 | 0.49 | 1.22 |
Other Operating Activities | 33.14 | 13.13 | 59.6 | -8.76 | -25.8 | 9.53 |
Change in Accounts Receivable | -8.59 | -10.67 | 10.06 | -17.67 | -20.05 | -3.94 |
Change in Inventory | -9.96 | -16.44 | -5.99 | -18.62 | 3.18 | -0.53 |
Change in Accounts Payable | 1.25 | 17.85 | -5.28 | -3.1 | 18.21 | 20.51 |
Change in Other Net Operating Assets | -4.85 | -2.53 | -1.97 | 9.66 | -16.49 | -0.73 |
Operating Cash Flow | 56.03 | 38.8 | 15.34 | -13.54 | 22.99 | 71.8 |
Operating Cash Flow Growth | 87.71% | 152.84% | - | - | -67.98% | 76.35% |
Capital Expenditures | -2.56 | -1.01 | -7.36 | -11.52 | -13.52 | -16.58 |
Cash Acquisitions | - | - | - | - | -262.87 | - |
Divestitures | 23.99 | 24.68 | 34.68 | - | - | - |
Sale (Purchase) of Intangibles | - | -0.71 | - | - | - | - |
Investment in Securities | - | - | - | - | -7.37 | -4.09 |
Other Investing Activities | - | - | -11.51 | -104.92 | - | 0.17 |
Investing Cash Flow | 21.44 | 22.96 | 15.81 | -116.44 | -283.76 | -20.5 |
Short-Term Debt Issued | - | - | - | - | - | 49 |
Long-Term Debt Issued | - | - | 64 | 104.66 | 277.45 | - |
Total Debt Issued | 76.91 | - | 64 | 104.66 | 277.45 | 49 |
Short-Term Debt Repaid | - | - | - | - | - | -49 |
Long-Term Debt Repaid | - | -59.58 | -87.26 | -45.04 | -111.25 | -10 |
Total Debt Repaid | -73.57 | -59.58 | -87.26 | -45.04 | -111.25 | -59 |
Net Debt Issued (Repaid) | 3.34 | -59.58 | -23.26 | 59.62 | 166.2 | -10 |
Issuance of Common Stock | 2.67 | 2.44 | 0.78 | 5.82 | 109.41 | - |
Repurchase of Common Stock | -0.01 | - | - | -3.35 | - | - |
Common Dividends Paid | - | - | - | - | - | -19.89 |
Dividends Paid | - | - | - | - | - | -19.89 |
Other Financing Activities | -82.55 | 2.56 | -4.17 | -0.02 | -2.24 | 0.32 |
Financing Cash Flow | -76.55 | -54.58 | -26.65 | 62.08 | 273.37 | -29.57 |
Foreign Exchange Rate Adjustments | -1.83 | -2.56 | 0.63 | 0.52 | -0.23 | 0.59 |
Net Cash Flow | -0.91 | 4.62 | 5.13 | -67.38 | 12.37 | 22.32 |
Free Cash Flow | 53.47 | 37.79 | 7.98 | -25.06 | 9.47 | 55.22 |
Free Cash Flow Growth | 84.09% | 373.43% | - | - | -82.85% | 43.91% |
Free Cash Flow Margin | 9.48% | 6.59% | 1.56% | -4.89% | 2.20% | 17.19% |
Free Cash Flow Per Share | 0.79 | 0.58 | 0.13 | -0.41 | 0.21 | 11.27 |
Cash Interest Paid | 38.51 | 38.51 | 32.47 | 18.04 | 5.84 | 7.49 |
Cash Income Tax Paid | 1.34 | 1.34 | 2.96 | 1.52 | 7.46 | 1.54 |
Levered Free Cash Flow | 33.88 | 67.03 | -108.45 | 92.14 | -25.11 | 52.53 |
Unlevered Free Cash Flow | 52.74 | 91.27 | -83.02 | 103.65 | -22.71 | 59.62 |
Change in Working Capital | -22.16 | -11.78 | -3.18 | -29.73 | -15.15 | 15.31 |
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.